Chronic Leukemias and Lymphomas
Biology, Pathophysiology, and Clinical Management
Seiten
2002
|
2003 ed.
Humana Press Inc. (Verlag)
978-0-89603-907-0 (ISBN)
Humana Press Inc. (Verlag)
978-0-89603-907-0 (ISBN)
Describing the unique biological features of indolent hematologic neoplasms, this work provides insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease.
In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights into the promising new era of antineoplastic pharmacology.
In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights into the promising new era of antineoplastic pharmacology.
1 Chronic Leukemias: History, Epidemiology, and Risk Factors.- 2 Chronic Lymphocytic Leukemia: Diagnosis and Management.- 3 Hairy Cell Leukemia: Biology, Diagnosis, and Treatment.- 4 Prolymphocytic Leukemias.- 5 Chronic Myeloid Leukemia.- 6 Sézary Syndrome: The Redefinition of a Clinico-Pathologic Entity and its Implication for Staging, Prognosis, and Treatment.- 7 Large Granular Lymphocyte Proliferative Diseases.- 8 Myeloproliferative Syndromes.- 9 Advances in the Biology and Treatment of Multiple Myeloma.- 10 Low-Grade Lymphoma.- 11 Aggressive Large-Cell Lymphomas.- 12 Hodgkin’s Disease.
| Erscheint lt. Verlag | 16.10.2002 |
|---|---|
| Reihe/Serie | Current Clinical Oncology |
| Zusatzinfo | 31 Illustrations, black and white; X, 342 p. 31 illus. |
| Verlagsort | Totowa, NJ |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| ISBN-10 | 0-89603-907-2 / 0896039072 |
| ISBN-13 | 978-0-89603-907-0 / 9780896039070 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Wie Leukämien und Lymphome bei Kindern heilbar wurden
Buch | Softcover (2025)
Lehmanns Media (Verlag)
CHF 41,90
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00
